Pathologic examination of sentinel lymph nodes from melanoma patients

Seminars in Diagnostic Pathology

Volumn 25, Issue 2, 2008, Pages 100-111

  Scolyer, Richard A ^a,b   Murali, Rajmohan ^a,b   McCarthy, Stanley W ^a,b   Thompson, John F ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Accuracy; False negative; Melanoma; Pathology; Protocol; Sentinel node

Indexed keywords

EOSIN; GLYCOPROTEIN GP 100; HEMATOXYLIN; KI 67 ANTIGEN; MELAN A; MELANOMA ANTIGEN; PROTEIN S 100;

ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CLINICAL PROTOCOL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DENDRITIC CELL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FALSE NEGATIVE RESULT; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MELANOMA; MELANOMA CELL; MICROMETASTASIS; NEEDLE BIOPSY; NEVUS CELL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; ULTRASOUND;

CLINICAL PROTOCOLS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SPECIMEN HANDLING; TUMOR BURDEN;

EID: 45849107633     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2008.04.002     Document Type: Article

References (64)

1. Cascinelli N., Belli F., Santinami M., et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 7 (2000) 469-474
2. Thompson J.F., Scolyer R.A., and Kefford R.F. Cutaneous melanoma. [see comment]. Lancet 365 (2005) 687-701
3. Clary B.M., Brady M.S., Lewis J.J., et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 233 (2001) 250-258
4. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17 (1999) 976-983
5. Jansen L., Nieweg O.E., Peterse J.L., et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 87 (2000) 484-489
6. Krag D.N., Meijer S.J., Weaver D.L., et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 130 (1995) 654-658 discussion 659-660
7. Morton D.L., Thompson J.F., Essner R., et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230 (1999) 453-463 discussion 463-465
8. Reintgen D., Cruse C.W., Wells K., et al. The orderly progression of melanoma nodal metastases. Ann Surg 220 (1994) 759-767
9. Thompson J.F., McCarthy W.H., Bosch C.M., et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 5 (1995) 255-260
10. Thompson J.F. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann Surg Oncol 8 suppl (2001) 44S-47S
11. Balch C.M., Soong S.J., Gershenwald J.E., et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 (2001) 3622-3634
12. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
13. McCarthy W.H., Shaw H.M., Cascinelli N., et al. Elective lymph node dissection for melanoma: two perspectives. World J Surg 16 (1992) 203-213
14. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355 (2006) 1307-1317
15. Diaz L.K., Hunt K., Ames F., et al. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 27 (2003) 385-389
16. Scolyer R.A., Thompson J.F., McCarthy S.W., et al. Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. [comment]. J Am Coll Surg 201 (2005) 821-823 author reply 823-824
17. Klausen T.L., Chakera A.H., Friis E., et al. Radiation doses to staff involved in sentinel node operations for breast cancer. Clin Physiol Funct Imaging 25 (2005) 196-202
18. Miner T.J., Shriver C.D., Flicek P.R., et al. Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node. Ann Surg Oncol 6 (1999) 75-82
19. Nejc D., Wrzesien M., Piekarski J., et al. Sentinel node biopsy in skin melanoma patients: measurements of absorbed doses of radiation to the hands of medical staff. J Surg Oncol 93 (2006) 355-361
20. Cochran A.J., Wen D.R., and Morton D.L. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol 12 (1988) 612-618
21. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16 (1998) 2253-2260
22. Yu L.L., Flotte T.J., Tanabe K.K., et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 86 (1999) 617-627
23. Baisden B.L., Askin F.B., Lange J.R., et al. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol 24 (2000) 1140-1146
24. Cook M.G., Green M.A., Anderson B., et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 200 (2003) 314-319
25. Gietema H.A., Vuylsteke R.J., de Jonge I.A., et al. Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 57 (2004) 618-620
26. Abrahamsen H.N., Hamilton-Dutoit S.J., Larsen J., et al. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 100 (2004) 1683-1691
27. Spanknebel K., Coit D.G., Bieligk S.C., et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 29 (2005) 305-317
28. Cochran A.J. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes. Am J Surg Pathol 23 (1999) 1169-1172
29. Cochran A.J., Roberts A., Wen D.R., et al. Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours. Pathology 36 (2004) 478-484
30. Yee V.S., Thompson J.F., McKinnon J.G., et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 12 (2005) 429-439 [Published erratum appears in Ann Surg Oncol 12:843, 2005]
31. Nowecki Z.I., Rutkowski P., Nasierowska-Guttmejer A., et al. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol 13 (2006) 1655-1663
32. van Akkooi A.C., de Wilt J.H., Verhoef C., et al. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 42 (2006) 372-380
33. Caraco C., Marone U., Celentano E., et al. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol 14 (2007) 2662-2667
34. Roulin D., Matter M., Bady P., et al. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution. Eur J Surg Oncol 34 (2008) 673-679
35. Riber-Hansen R., Sjoegren P., Hamilton-Dutoit S.J., et al. Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload. Ann Surg Oncol 15 (2008) 1492-1501
36. Scolyer R.A., Thompson J.F., and McCarthy S.W. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. [comment]. Cancer 101 (2004) 2141-2142 author reply 2142-2143
37. Li L.X., Scolyer R.A., Ka V.S., et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol 27 (2003) 1197-1202
38. Gadd M.A., Cosimi A.B., Yu J., et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 134 (1999) 381-387
39. Cochran A.J., Wen D.R., Huang R.R., et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 17 (2004) 747-755
40. Dewar D.J., Newell B., Green M.A., et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22 (2004) 3345-3349
41. Scolyer R.A., Li L.X., McCarthy S.W., et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 122 (2004) 532-539
42. Starz H., Balda B.R., Kramer K.U., et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 91 (2001) 2110-2121
43. Pearlman N.W., McCarter M.D., Frank M., et al. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg 192 (2006) 878-881
44. Debarbieux S., Duru G., Dalle S., et al. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol 157 (2007) 58-67
45. Govindarajan A., Ghazarian D.M., McCready D.R., et al. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol 14 (2007) 906-912
46. Sabel M.S., Griffith K., Sondak V.K., et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 201 (2005) 37-47
47. Murali R., Cochran A.J., Cook M.G., et al. Interobserver reproducibility of the assessment of morphometric features of sentinel lymph nodes containing metastatic melanoma. Ann Surg Oncol 15 suppl 1 (2008) 29-30
48. van Akkooi A.C., de Wilt J.H., Verhoef C., et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?. Ann Oncol 17 (2006) 1578-1585
49. Satzger I., Volker B., Meier A., et al. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Am J Surg Pathol 31 (2007) 1175-1180
50. Dawson M., Doble P., Beavis A., et al. Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients. Analyst 128 (2003) 217-219
51. Scolyer R.A., Thompson J.F., Li L.X., et al. Antimony concentrations in nodal tissue can confirm sentinel node identity. Mod Pathol 17 (2004) 1191-1197
52. Scolyer R.A., Thompson J.F., Li L.X., et al. Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: evidence from antimony concentrations in false-negative sentinel nodes from melanoma patients. Ann Surg Oncol 11 suppl (2004) 174S-178S
53. Morton D.L., Hoon D.S., Cochran A.J., et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 238 (2003) 538-549 discussion 549-550
54. Haigh P.I., Lucci A., Turner R.R., et al. Carbon dye histologically confirms the identity of sentinel lymph nodes in cutaneous melanoma. Cancer 92 (2001) 535-541
55. Karim R.Z., Scolyer R.A., Li W., et al. False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery and/or pathology. Ann Surg 247 (2008) 1003-1010
56. Giese T., Engstner M., Mansmann U., et al. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR. J Invest Dermatol 124 3 (2005) 633-637
57. Blaheta H.J., Ellwanger U., Schittek B., et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 114 4 (2000) 637-642
58. Bostick P.J., Morton D.L., Turner R.R., et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 17 10 (1999) 3238-3244
59. Stretch J.R., Somorjai R., Bourne R., et al. Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples. Ann Surg Oncol 12 11 (2005) 943-949
60. Beavis A., Dawson M., Doble P., et al. Sentinel lymph node identity confirmed by analysis of fine needle biopsy samples using inductively coupled plasma-mass spectrometry. Ann Surg Oncol (2007) in press
61. Starritt E.C., Uren R.F., Scolyer R.A., et al. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol 12 1 (2005) 18-23
62. Rossi C.R., Mocellin S., Scagnet B., et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol 83 2 (2003) 80-84
63. Voit C., Van Akkooi A.C., Schafer-Hesterberg G., et al. Role of ultrasound (US) and US-guided fine needle aspiration cytology (US-FNAC) prior to sentinel lymph node biopsy (SLNB) in 500 melanoma patients: Reduction of need for SNLB by high US-FNAC SN positive identification rate. J Clin Oncol 25 18S (2007) 8512
64. Morton D.L., Thompson J.F., and Cochran A.J. Sentinel-node biopsy in melanoma. N Engl J Med 356 (2007) 419-421